Dr. Lucy Abgaryan, the co-founder and CEO of GrittGene Therapeutics, a biotech company based in Los Angeles, California, joins us to discuss how her company is working to find treatments for Myotonic Dystrophy, a rare genetic disorder that causes progressive muscle loss and weakness. Lucy also shared with us her experience in trying to find opportunities to work with the local Armenian biotech industry.
This week on EVN Disrupt, Marina Aghayan, the co-founder of AIP Tech and Fact Industries, joins us to discuss the potential that 3D printing has for solving real-world problems. AIP Tech is an Armenian company that 3D prints devices for the medical and aerospace industries. AIP Tech volunteered to help veterans of the 2020 Artsakh War with varying bone injuries with customized 3D implants to help them return to normal life.
Zareh Zurabyan, the head of the Americas division at eLabNext, a European biotech company, joins us to discuss problems the biotech industry is currently working to solve. Zareh describes who the different players in biotech ecosystems are and what trends he is seeing in the industry in 2022. We also discussed his efforts to mentor Armenian start-ups and his thoughts on Armenia’s biotech scene.
EVN Report’s mission is to empower Armenia, inspire the diaspora and inform the world through sound, credible and fact-based reporting and commentary. Our goal is to increase public trust in the media. EVN Report is the media arm of EVN News Foundation registered in the Republic of Armenia in 2017.
